Students were taught about the chemistry behind developing cancer treatments in the Oslo Cancer Cluster Incubator.
Student Jørgen Amdim got to experience life as an orderly at the Radium Hospital.
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
Dr. Jon Amund Kyte at Oslo University Hospital aims to bring more and better clinical trials to Norway.
Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]